Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

Johnson, 1995, Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center, J Clin Oncol, 13, 140, 10.1200/JCO.1995.13.1.140 van Besien, 1998, Allogeneic bone marrow transplantation for low-grade lymphoma, Blood, 92, 1832 van Besien, 2003, Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma, Blood, 102, 3521, 10.1182/blood-2003-04-1205 Storb, 2001, Non-myeloablative transplants for malignant disease, Hematology (Am Soc Hematol Educ Program), 375, 10.1182/asheducation-2001.1.375 Slavin, 1998, Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases, Blood, 91, 756, 10.1182/blood.V91.3.756 Morris, 2004, Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma, Blood, 104, 3865, 10.1182/blood-2004-03-1105 Khouri, 2004, Nonmyeloablative stem cell transplantation for lymphoma, Semin Oncol, 31, 22, 10.1053/j.seminoncol.2003.10.017 Faulkner, 2004, BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients, Blood, 103, 428, 10.1182/blood-2003-05-1406 Medeiros, 2002, Fatal aplasia and graft rejection after nonmyeloablative allografting, Blood, 100, #1613 Thomas, 1961, Autogenous recovery of marrow function. Recovery after general exposure to 1082 roentgens of Co60 radiation at 36 roentgens per hour, Arch Intern Med, 107, 395, 10.1001/archinte.1961.03620030083012 Branch, 1982, Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia, Transplantation, 34, 226, 10.1097/00007890-198210000-00018 Giralt, 2001, Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation, Blood, 97, 631, 10.1182/blood.V97.3.631 Martino, 2006, Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes, Blood, 108, 836, 10.1182/blood-2005-11-4503 Crawley, 2007, Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning, Blood, 109, 3588, 10.1182/blood-2006-07-036848 Klein, 2003 Kaplan, 1958, Nonparametric estimation for incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Zhang, 2001, Confidence bands for the difference of 2 survival curves under proportional hazards model, Lifetime Data Anal, 7, 243, 10.1023/A:1011636407958 Clark, 2002, Quantification of the completeness of follow-up, Lancet, 359, 1309, 10.1016/S0140-6736(02)08272-7 Klein, 2001, Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling, Bone Marrow Transplant, 28, 1001, 10.1038/sj.bmt.1703271 van Besien, 1995, Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management, J Clin Oncol, 13, 1096, 10.1200/JCO.1995.13.5.1096 Robinson, 2002, Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation, Blood, 100, 4310, 10.1182/blood-2001-11-0107 Maris, 2005, Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for relapsed or refractory follicular lymphoma, ASH Annu Meet Abstr, 106, 1130 Diaconescu, 2004, Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors, Blood, 104, 1550, 10.1182/blood-2004-03-0804 Vigouroux, 2006, Allogeneic stem cell transplantation with reduced intensity conditioning for the treatment of patients with relapsed low-grade lymphoma: a report of the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC), Bone Marrow Transplant, 37, #241 Rodriguez, 2006, Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma, Biol Blood Marrow Transplant, 12, 1326, 10.1016/j.bbmt.2006.08.035 Devetten, 2006, Unrelated donor nonmyeloablative/reduced intensity (NST/RIC) hematopoietic stem cell transplantation (HCT) for patients with relapsed and refractory Hodgkin's lymphoma (HL), ASH Ann Meet Abstr, 108, 601 Sorror, 2004, Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities, Blood, 104, 961, 10.1182/blood-2004-02-0545 Schmitz, 2006, Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation, Blood, 108, 4288, 10.1182/blood-2006-05-024042 Anderson, 2003, A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections, Biol Blood Marrow Transplant, 9, 52, 10.1053/bbmt.2003.50000 Dreger, 2005, Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis, Leukemia, 19, 1029, 10.1038/sj.leu.2403745